insights

Burjeel Holdings has partnered with Hippocratic AI to transform healthcare in the UAE with a multilingual AI agent. Speaking over 15 languages, including Emirati Arabic and Mandarin, this innovative technology offers real-time, empathetic support to patients. Integrated into Burjeel’s platforms, these AI agents assist with appointment scheduling and health education while focusing on cultural contexts. With a clinical accuracy rate of 99.38%, this initiative enhances patient engagement and streamlines healthcare delivery. Discover how this partnership will shape the future of healthcare in the region!

Burjeel Holdings has partnered with Hippocratic AI to transform healthcare in the UAE and Oman through innovative AI solutions. Announced during Abu Dhabi Global Healthcare Week, this collaboration aims to enhance patient engagement with multilingual, culturally aware AI that streamlines appointments and follow-up care. By integrating advanced technology with personalized care, the initiative seeks to reduce wait times and improve clinical outcomes, making compassionate care more accessible.

Burjeel Holdings and Hippocratic AI are transforming healthcare in the UAE and Oman with empathetic, multilingual generative AI agents. These solutions enhance patient experiences by managing non-diagnostic tasks across specialties like oncology and cardiology. With a 99.38% accuracy rate, Hippocratic AI’s Polaris 3.0 platform aims to provide compassionate care, tackle staffing challenges, and reduce wait times. Discover how this partnership is shaping AI-powered, patient-centered healthcare in the MENA region.

WellSpan Health is redefining healthcare innovation with a strategy that integrates technology and human-centered design. Guided by Chief Innovation Officer Mark Kandrysawtz, the organization addresses workforce shortages and aging populations with innovative solutions. A key example is their collaboration with Hippocratic AI on Ana, a conversational AI assistant that improves patient experiences during procedures. Discover how WellSpan is leading change through strategic partnerships, enhancing efficiency, personalization, and clinical quality in healthcare.

Digital health funding is off to a strong start in 2025, with US startups securing $3 billion in Q1—a notable 11% increase from last year. The rise in deal sizes and late-stage funding highlights a vibrant investment landscape. Significant transactions, like Open Evidence’s $75 million Series A and Hippocratic AI’s $141 million Series B, reflect growing confidence in healthcare technologies. Explore how these trends are shaping the future of digital health for investors and startups. Read the full article here.

AI agents are transforming health care by engaging with patients and performing essential tasks like chronic disease monitoring. Unlike traditional AI tools, these agents enhance patient care through automation. Companies like Hippocratic AI are developing AI-powered “nurses” to manage patient interactions on key health topics. As these technologies integrate, the health sector faces challenges in safety and oversight. Discover how AI agents are shaping the future of health care for patients and providers.

In the first quarter of 2025, U.S. digital health companies raised $3 billion across 122 deals, a significant change in investment trends. Average deal sizes rose from $15.5 million to $24.4 million, with early-stage startups making up 83% of these deals. Noteworthy rounds, like Hippocratic AI’s $141 million Series B, reflect growing investor confidence. Moreover, three late-stage deals surpassed $100 million, highlighting strong interest in mature companies. Discover the insights shaping the digital health landscape!

In Q1 of 2025, the U.S. digital health sector showed cautious optimism with $3.8 billion in funding across 122 deals. While transactions decreased, the average deal size increased, indicating a shift toward larger investments. Early-stage rounds accounted for 83% of all deals, though notable exceptions like Hippocratic AI’s $141 million Series B stood out. A key theme was “leapfrogging,” where companies evolve through strategic partnerships and acquisitions. Discover how leading firms are adapting to this rapidly changing landscape.

Agentic AI is transforming healthcare with its autonomous decision-making, enabling real-time diagnostics, treatment optimization, and patient monitoring. With a projected market growth rate of 35–40% over the next five years, this technology addresses critical issues like workforce shortages and the demand for personalized care. Innovators like Hippocratic AI Inc. are leading the charge, while advancements in machine learning and natural language processing expand the potential of agentic AI. Discover how this technology is reshaping healthcare and the future of patient care.